Atlas Trials

Taizhou Hospital

23 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Taizhou Hospital

RecordFirmDate
Enhancing Critical Thinking Competency and Nursing Quality in Critically Ill Patient Care (NCT06997614)Taizhou Hospital2025-05-25
Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound (NCT06902935)Taizhou Hospital2025-04-26
Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell (NCT06441344)Taizhou Hospital2024-07-01
Mindfulness-Based Intervention Targeting Psychological Capital to Reduce Job Burnout Among Nurses (NCT07127809)Taizhou Hospital2024-05-01
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases (NCT06319950)Taizhou Hospital2024-04-01
Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients (NCT07686939)Taizhou Hospital2023-01-01
Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy (NCT05817201)Taizhou Hospital2022-07-01
Identification of the Optimal Functional Lymphatic Vessel for Lymphaticovenous Anastomosis (NCT06191081)Taizhou Hospital2022-01-01
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma (NCT04813705)Taizhou Hospital2022-01-01
Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer (NCT04918628)Taizhou Hospital2021-05-01
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC (NCT04363255)Taizhou Hospital2020-05-01
Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema (NCT06188858)Taizhou Hospital2020-01-01
Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases (NCT03732482)Taizhou Hospital2019-03-01
S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer (NCT03823118)Taizhou Hospital2019-03-01
Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer (NCT05880927)Taizhou Hospital2019-01-01
CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients (NCT03732430)Taizhou Hospital2018-11-14

Track Taizhou Hospital automatically

Every clearance here is in the API, with alerts when new ones post.